Juan R. Gimeno

Murcia, MU, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1: A Multicenter Study.

Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1: A Multicenter Study.

Journal: JACC. Advances

Published: January 27, 2026

External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants.

External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants.

Journal: Heart rhythm

Published: January 15, 2026

Heparin pretreatment for STEMI primary angioplasty: a meta-analysis.

Heparin pretreatment for STEMI primary angioplasty: a meta-analysis.

Journal: REC, interventional cardiology

Published: December 03, 2025

Heparin pretreatment for STEMI primary angioplasty: a meta-analysis.

Heparin pretreatment for STEMI primary angioplasty: a meta-analysis.

Journal: REC, interventional cardiology

Published: December 03, 2025

Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry.

Genetic anticipation and cardiac conduction abnormalities in myotonic dystrophy type 1: implications for early stratification from a multicenter registry.

Journal: International journal of cardiology. Heart & vasculature

Published: October 31, 2025

Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial.

Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial.

Journal: Journal of the American College of Cardiology

Published: September 04, 2025

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

Journal: medRxiv : the preprint server for health sciences

Published: July 16, 2025

Childhood-onset RASopathy-associated hypertrophic cardiomyopathy, diastolic dysfunction, and arrhythmias.

Childhood-onset RASopathy-associated hypertrophic cardiomyopathy, diastolic dysfunction, and arrhythmias.

Journal: European heart journal

Published: June 16, 2025

Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.

Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.

Journal: European heart journal

Published: April 16, 2025

NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.

NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.

Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Published: April 10, 2025

Impact of physical activity on presentation and prognosis of Brugada syndrome.

Impact of physical activity on presentation and prognosis of Brugada syndrome.

Journal: Open heart

Published: December 20, 2024

Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study.

Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study.

Journal: Revista espanola de cardiologia (English ed.)

Published: December 19, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026